Most recent update: Monday, January 27, 2020 - 11:36

Bariatric News - Cookies & privacy policy

You are here

Surgery and testosterone production

Bariatric surgery can rapidly restore testosterone production

While obese males show an elevated prevalence of hypogonadism, this is rapidly reversed (within one month) after significant weight loss following bariatric surgery

Sleeve gastrectomy (can rapidly reverse obesity-related hypogonadism in morbidly obese men, restoring normal levels of testosterone and sex drive, according to a study by researchers from the University of Padova, Italy, presented at the European Congress on Obesity (ECO) in Vienna, Austria.

Obesity in men is associated with hypogonadism; a condition in which production of testosterone is reduced, while oestrogen levels are elevated. These effects seem to be the result of excess body fat interfering with sex steroid metabolism which leads to increased aromatisation of androgens (such as testosterone) into oestrogens within the adipose tissue itself. It follows that weight loss should improve this hormonal imbalance and contribute to a reversal of hypogonadism.

Current hypogonadism research has been limited to evaluating the effects of weight loss on male hypogonadism a long time after the reduction in body fat has occurred, so it was not known how rapidly hormones began to return to normal in human subjects. The goal of this study, conducted by Professor Marco Rossato and colleagues, was to investigate levels of sex steroids immediately after rapid weight loss in a group of obese men who had undergone bariatric surgery, to determine how quickly those changes occurred.

The authors selected a group of 29 obese men with an average age of 40.5 years and an average BMI 43.4k. Blood tests were performed to measure total plasma testosterone, the sex hormones dihydrotestosterone (DHT), oestradiol, luteinising hormone (LH), follicle-stimulating hormone (FSH), as well as sex hormone binding globulin (SHBG), prostatic-specific antigen (PSA) and leptin in subjects before and one month after they underwent a sleeve gastrectomy. As a control, the team studied a group of 19 healthy age-matched, non-obese male subjects.

The study found that among the obese subjects, 51.6% had hypogonadism and of those who had subnormal total testosterone, those with metabolic syndrome (45.2%) showed lower plasma testosterone than men without metabolic syndrome. BMI and waist circumference were found to be negatively correlated with total testosterone and plasma LH levels. Obese males had lower plasma testosterone than healthy subjects (10.8 vs. 15.7 nmol/L), higher oestradiol levels (124.4 vs. 78.8 pmol/L), lower LH and FSH levels (3.6 and 2.5 vs 5.2 and 5.9 IU/L respectively). No differences were observed between the two groups in their DHT and PSA levels.

One month after the sleeve gastrectomy, obese subjects showed a significant weight reduction, averaging 17.2kg and the proportion with hypogonadism had fallen to 11.6%. Average testosterone levels increased by 85%, to a level greater than that observed in the healthy control group (18.9 vs 15.7 nmol/L). Estradiol levels fell by 35% while PSA levels rose by 70%.

The study demonstrates that while obese males show an elevated prevalence of hypogonadism, this is rapidly reversed (within one month) after significant weight loss following bariatric surgery. Testosterone levels are increased significantly while oestradiol levels fall due to the rapid and significant loss of fat mass and the consequent decrease in aromatisation of androgens to oestrogens that typically occur in adipose tissue.

"The clinical significance of the rapid increase in PSA plasma levels observed one month after bariatric surgery is still obscure and has to be confirmed on a larger number of subjects and after a longer period of observation after surgery and weight reduction maintenance,” the authors conclude. “It could be due to the rapid testosterone increase stimulating the prostate and/or to the rapid reduction in plasma volume after weight loss…If you consider that obese males, as with all people with obesity, have higher prevalence of some type of cancer, including prostate cancer for men, this information could be of importance, since it could lead to doctors potentially missing cases of severe prostate disease in obese men."

The authors also add a note of caution regarding low PSA levels that can be observed in obese men, since these can underestimate the true levels of PSA that would be seen if these men were normal weight.

Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox. NOTE: Bariatric News WILL NOT pass on your details to 3rd parties. However, you may receive ‘marketing emails’ sent by us on behalf of 3rd parties.